These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27291832)

  • 1. Cardiovascular and metabolic monitoring of children and adolescents on antipsychotic treatment: A cross-sectional descriptive study.
    de la Torre Villalobos M; Martin-López LM; Fernández Sanmartín MI; Pujals Altes E; Gasque Llopis S; Batlle Vila S; Pérez-Solá V; Novo Navarro P; Gómez Simón I; Fresno González C; Camprodon Rosanas E; Bulbena Vilarrasa A
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(1):19-26. PubMed ID: 27291832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone and Cardiometabolic Risk in Children and Adolescents: Clinical and Instrumental Issues.
    Matera E; Margari L; Palmieri VO; Zagaria G; Palumbi R; Margari F
    J Clin Psychopharmacol; 2017 Jun; 37(3):302-309. PubMed ID: 28338545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
    McIntyre RS; Jerrell JM
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.
    Coughlin M; Goldie CL; Tranmer J; Khalid-Khan S; Tregunno D
    Can J Psychiatry; 2018 Apr; 63(4):240-249. PubMed ID: 29528720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
    De Hert M; Detraux J; van Winkel R; Yu W; Correll CU
    Nat Rev Endocrinol; 2011 Oct; 8(2):114-26. PubMed ID: 22009159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
    Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
    Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system.
    Leung JY; Barr AM; Procyshyn RM; Honer WG; Pang CC
    Pharmacol Ther; 2012 Aug; 135(2):113-22. PubMed ID: 22565090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients.
    Mackin P; Bishop DR; Watkinson HM
    BMC Psychiatry; 2007 Jun; 7():28. PubMed ID: 17592636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.
    Siskind D; Hahn M; Correll CU; Fink-Jensen A; Russell AW; Bak N; Broberg BV; Larsen J; Ishøy PL; Vilsbøll T; Knop FK; Kisely S; Ebdrup BH
    Diabetes Obes Metab; 2019 Feb; 21(2):293-302. PubMed ID: 30187620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipsychotic prescription assessment in general practice: metabolic effects].
    Gignoux-Froment F; de Montleau F; Saravane D; Verret C
    Encephale; 2012 Dec; 38(6):453-9. PubMed ID: 23200610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients.
    Ebdrup BH; Knop FK; Madsen A; Mortensen HB; Søgaard B; Holst JJ; Szecsi PB; Lublin H
    J Clin Psychiatry; 2014 Sep; 75(9):e899-905. PubMed ID: 25295432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health Centre.
    Tarricone I; Casoria M; Gozzi BF; Grieco D; Menchetti M; Serretti A; Ujkaj M; Pastorelli F; Berardi D
    BMC Psychiatry; 2006 Mar; 6():11. PubMed ID: 16542430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of Metabolic Adverse Effects Associated With Atypical Antipsychotics Use in an Outpatient Psychiatric Clinic.
    Pereira L; Budovich A; Claudio-Saez M
    J Pharm Pract; 2019 Aug; 32(4):388-393. PubMed ID: 29334810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and safety profile of risperidone in a sample of children and adolescents.
    Margari L; Matera E; Craig F; Petruzzelli MG; Palmieri VO; Pastore A; Margari F
    Int Clin Psychopharmacol; 2013 Jul; 28(4):177-83. PubMed ID: 23689836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary care providers' views on metabolic monitoring of outpatients taking antipsychotic medication.
    Mangurian C; Giwa F; Shumway M; Fuentes-Afflick E; Pérez-Stable EJ; Dilley JW; Schillinger D
    Psychiatr Serv; 2013 Jun; 64(6):597-9. PubMed ID: 23728604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.